APA (7th ed.) Citation

A, S., A, B., I, S., V, N., T, S., S, B., . . . K, A. (2025). Advanced Cardiovascular Toxicity Screening: Integrating Human iPSC-Derived Cardiomyocytes with 2D In Silico Models. Cardiovascular toxicology, 25(5), 790. https://doi.org/10.1007/s12012-025-09987-1

Chicago Style (17th ed.) Citation

A, Sinitsyna, Berezhnoy A, Semidetnov I, Naumov V, Sergeeva T, Bakumenko S, Slotvitsky M, Tsvelaya V, and Agladze K. "Advanced Cardiovascular Toxicity Screening: Integrating Human IPSC-Derived Cardiomyocytes with 2D In Silico Models." Cardiovascular Toxicology 25, no. 5 (2025): 790. https://doi.org/10.1007/s12012-025-09987-1.

MLA (9th ed.) Citation

A, Sinitsyna, et al. "Advanced Cardiovascular Toxicity Screening: Integrating Human IPSC-Derived Cardiomyocytes with 2D In Silico Models." Cardiovascular Toxicology, vol. 25, no. 5, 2025, p. 790, https://doi.org/10.1007/s12012-025-09987-1.